Trevi Therapeutics, Inc. (NASDAQ:TRVI)

About the company

Trevi Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of treatment for neurologically mediated conditions. It focuses on the formulation of nalbuphine ER, which use to treat chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good on March 17, 2011 and is headquartered in New Haven, CT.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

17

$NoneM

Total Revenue

17

Employees

$125.64M

Market Capitalization

-4.28

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 382757.45 82729.00 6.15 22.31 20.75
Merck & Co., Inc. MRK 201995.52 48081.00 7.58 19.93 21.10
Pfizer Inc. PFE 191963.22 50660.00 2.91 12.15 31.17
Eli Lilly & Co. LLY 153076.50 23087.00 51.95 26.98 23.97
AbbVie, Inc. ABBV 146930.84 34057.00 -23.52 17.52 24.65
Bristol Myers Squibb Co. BMY 113009.51 31006.00 2.74 96.08 3.08
Repligen Corp. RGEN 6456.09 286.00 6.19 281.31 8.11
Reata Pharmaceuticals, Inc. RETA 4973.33 20.00 23.56 -16.00 -150.30
Nektar Therapeutics NKTR 4248.64 137.00 3.32 -9.25 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3748.16 1.00 34.65 -5.73 None
Allakos, Inc. ALLK 3122.21 None 6.78 -33.38 None
Karuna Therapeutics, Inc. KRTX 2853.24 None 7.45 -70.35 None
ADC Therapeutics SA ADCT 2565.54 2.00 30.26 -22.00 None
OPKO Health, Inc. OPK 2332.47 891.00 1.66 -7.98 -32.92
Turning Point Therapeutics, Inc. TPTX 2259.00 None 6.80 -18.90 None
IGM Biosciences, Inc. IGMS 2244.09 None 9.89 -41.37 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1681.30 None 5.46 -26.97 None
Zymeworks, Inc. ZYME 1622.04 26.00 3.37 -9.56 -629.37
Principia Biopharma, Inc. PRNB 1604.12 30.00 5.71 -22.82 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1578.42 None 9.67 -17.13 None
Akcea Therapeutics, Inc. AKCA 1360.91 341.00 2.79 -48.38 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1305.15 None 6.76 -10.79 None
Tricida, Inc. TCDA 1301.44 None 6.69 -6.16 None
Arcutis Biotherapeutics, Inc. ARQT 1194.36 None 5.09 -19.10 None
Odonate Therapeutics, Inc. ODT 1150.14 None 9.42 -10.22 None
Phibro Animal Health Corp. PAHC 1077.48 818.00 5.44 29.20 4.49
Akero Therapeutics, Inc. AKRO 1074.74 None 8.97 -21.18 None
Athenex, Inc. ATNX 1064.70 123.00 6.53 -9.89 -87.86
Constellation Pharmaceuticals, Inc. CNST 966.40 None 4.55 -10.41 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Phathom Pharmaceuticals, Inc. PHAT 808.50 None 4.49 -2.97 None
Oric Pharmaceuticals, Inc. ORIC 800.80 None -8.69 -26.48 None
Gossamer Bio, Inc. GOSS 793.61 None 3.22 -3.99 None
Aprea Therapeutics, Inc. APRE 769.86 None 6.81 -22.77 None
Quanterix Corp. QTRX 752.76 60.00 6.64 -17.21 -71.52
Krystal Biotech, Inc. KRYS 731.00 None 4.26 -35.25 None
Applied Therapeutics, Inc. APLT 712.58 14.00 4.60 -14.46 -19.41
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Amneal Pharmaceuticals, Inc. AMRX 621.98 1679.00 4.28 -2.86 -11.85
Keros Therapeutics, Inc. KROS 606.78 8.00 -27.41 -28.57 -285.35
Arcturus Therapeutics Holdings, Inc. ARCT 605.28 19.00 56.10 -21.76 -151.34
Oyster Point Pharma, Inc. OYST 554.61 None 5.57 -9.64 None
Mirum Pharmaceuticals, Inc. MIRM 486.50 None 3.16 -7.18 None
Satsuma Pharmaceuticals, Inc. STSA 476.00 None 4.68 -13.08 None
SIGA Technologies, Inc. SIGA 475.60 19.00 5.32 -24.17 -94.00
Biospecifics Technologies Corp. BSTC 466.97 40.00 3.79 19.97 61.80
89bio, Inc. ETNB 462.70 None 5.71 -7.17 None
Imara, Inc. IMRA 438.60 None 4.24 -12.46 None
Fulcrum Therapeutics, Inc. FULC 419.75 1.00 7.07 -6.08 None
DURECT Corp. DRRX 416.64 28.00 32.00 -17.23 -82.94
Crinetics Pharmaceuticals, Inc. CRNX 414.72 1.00 5.24 -7.11 -447.78
Ocular Therapeutix, Inc. OCUL 383.04 6.00 -46.94 -4.18 None
Kala Pharmaceuticals, Inc. KALA 379.08 6.00 4.15 -4.13 None
Relmada Therapeutics, Inc. RLMD 377.19 0.00 5.63 -31.51 -877.66
TCR2 Therapeutics, Inc. TCRR 373.20 None 2.55 -37.02 None
Osmotica Pharmaceuticals Plc OSMT 361.80 232.00 2.75 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 321.75 None 7.61 -4.93 None
Urovant Sciences Ltd. UROV 302.10 None -5.36 -2.09 None
Aeglea Biotherapeutics, Inc. AGLE 298.98 4.00 9.44 -3.73 -523.27
HOOKIPA Pharma, Inc. HOOK 282.88 13.00 2.56 -6.25 -333.02
IDEAYA Biosciences, Inc. IDYA 274.60 None 4.17 -6.30 None
Lannett Co., Inc. LCI 270.18 542.00 0.92 -8.89 -5.77
AMAG Pharmaceuticals, Inc. AMAG 268.26 321.00 1.02 -0.72 -115.05
Spero Therapeutics, Inc. SPRO 261.63 12.00 3.44 -3.22 -656.72
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Gritstone Oncology, Inc. GRTS 240.84 4.00 2.16 -2.31 None
Kaleido Biosciences, Inc. KLDO 221.10 None 7.84 -3.02 None
KalVista Pharmaceuticals, Inc. KALV 219.60 12.00 2.43 -6.78 -263.38
Veru, Inc. VERU 207.35 39.00 6.93 -21.27 -25.53
Galera Therapeutics, Inc. GRTX 183.75 None 3.43 -2.79 None
LogicBio Therapeutics, Inc. LOGC 179.63 1.00 5.42 -4.22 None
Liquidia Technologies, Inc. LQDA 173.14 8.00 13.57 -3.51 -602.17
Sutro Biopharma, Inc. STRO 171.12 41.00 3.25 -2.81 -148.06
Protara Therapeutics, Inc. TARA 166.14 None 2.50 -10.77 None
Evolus, Inc. EOLS 159.60 45.00 2.86 -1.57 -217.51
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Avenue Therapeutics, Inc. ATXI 155.20 532.00 28.53 -10.66 26.69
Tyme Technologies, Inc. TYME 144.90 None 8.40 -6.63 None
Evelo Biosciences, Inc. EVLO 143.36 None 5.27 -1.64 None
scPharmaceuticals, Inc. SCPH 136.04 119.00 3.48 -4.34 -27.05
Harrow Health, Inc. HROW 133.38 51.00 8.55 -5.40 -47.54
Lyra Therapeutics, Inc. LYRA 129.96 1.00 -1.10 -7.79 -491.16
Aquestive Therapeutics, Inc. AQST 128.24 49.00 -7.39 -1.82 -139.64
Mustang Bio, Inc. MBIO 128.00 None 2.99 -2.60 None
PhaseBio Pharmaceuticals, Inc. PHAS 126.73 2.00 2.35 -2.65 None
Trevi Therapeutics, Inc. TRVI 125.64 None 2.66 -4.28 None
NeuBase Therapeutics, Inc. NBSE 122.22 None 51.35 -2.74 None
TFF Pharmaceuticals, Inc. TFFP 118.18 None 4.57 -3.05 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
Ayala Pharmaceuticals, Inc. AYLA 116.40 3.00 -2.74 -5.64 -679.19
Eton Pharmaceuticals, Inc. ETON 99.90 1.00 10.88 -5.00 None
Milestone Pharmaceuticals, Inc. MIST 95.00 None 0.94 -1.53 None
Corvus Pharmaceuticals, Inc. CRVS 79.46 None 1.27 -1.68 None
EyePoint Pharmaceuticals, Inc. EYPT 78.48 26.00 5.54 -1.60 -196.30
Clearside Biomedical, Inc. CLSD 77.49 6.00 9.95 -4.40 -293.61
Xeris Pharmaceuticals, Inc. XERS 74.48 4.00 3.69 -0.57 None
Checkpoint Therapeutics, Inc. CKPT 70.80 2.00 6.10 -3.05 -949.53
Navidea Biopharmaceuticals, Inc. NAVB 68.34 1.00 -50.25 -6.18 -65.13
Baudax Bio, Inc. BXRX 67.32 None -1.83 -0.96 None
BiomX, Inc. PHGE 64.35 None 1.70 -1.50 None
Genprex, Inc. GNPX 59.85 None 5.08 -4.38 None
Aridis Pharmaceuticals, Inc. ARDS 58.50 1.00 -24.07 -2.00 -851.00
Assertio Therapeutics, Inc. ASRT 58.32 192.00 1.01 -0.36 -83.99
Aerpio Pharmaceuticals, Inc. ARPO 52.89 20.00 1.59 -2.80 -51.58
Menlo Therapeutics, Inc. MNLO 49.01 2.00 4.12 -0.52 -483.51
Eyenovia, Inc. EYEN 45.44 None 4.58 -2.22 None
Edesa Biotech, Inc. EDSA 44.82 0.00 6.38 -0.47 -395.23
Moleculin Biotech, Inc. MBRX 40.94 None 3.56 -4.45 None
Citius Pharmaceuticals, Inc. CTXR 36.45 None 2.70 -2.11 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Mannatech, Inc. MTEX 34.80 156.00 1.47 7.84 3.45
Allena Pharmaceuticals, Inc. ALNA 33.58 None 4.42 -0.77 None
Oncternal Therapeutics, Inc. ONCT 33.54 3.00 4.30 -1.33 -225.89
AgeX Therapeutics, Inc. AGE 33.44 2.00 -44.00 -2.75 -658.11
Aileron Therapeutics, Inc. ALRN 32.20 None 4.42 -1.21 None
Acer Therapeutics, Inc. ACER 31.20 3.00 2.28 -1.20 -274.69
CNS Pharmaceuticals, Inc. CNSP 31.20 None 5.42 -5.74 None
Adamis Pharmaceuticals Corp. ADMP 30.16 22.00 1.16 -1.02 -140.33
Annovis Bio, Inc. ANVS 26.88 None 2.46 -21.33 None
Millendo Therapeutics, Inc. MLND 25.80 0.00 0.61 -0.55 None
Hoth Therapeutics, Inc. HOTH 25.00 None 6.94 -2.78 None
Spring Bank Pharmaceuticals, Inc. SBPH 24.64 0.00 0.93 -0.94 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.81 1.00 8.25 -1.13 None
ProPhase Labs, Inc. PRPH 16.80 9.00 1.52 -5.60 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.21 5.00 -3.27 -0.45 -602.34
Adial Pharmaceuticals, Inc. ADIL 13.80 None 3.37 -1.82 None
Titan Pharmaceuticals, Inc. TTNP 12.00 4.00 5.00 -0.67 -437.91
PDS Biotechnology Corp. PDSB 11.97 None 1.33 -0.47 None
Novus Therapeutics, Inc. NVUS 7.35 None 0.63 -0.35 None
Brickell Biotech, Inc. BBI 4.95 5.00 1.62 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Trevi Therapeutics Announces Election of Dominick C. Colangelo to Board of Directors

7d ago, source: YAHOO!

Mr. Colangelo joins Trevi’s Board with more than twenty years of executive management and corporate development experience in the biopharmaceutical industry, including nearly a decade with Eli Lilly ...

BRIEF-Trevi Therapeutics Files For Mixed Shelf Of Up To $150 Million

3d ago, source: Reuters

TREVI THERAPEUTICS FILES FOR MIXED SHELF OF UP TO $150 MILLION - SEC FILING Source text: [bit.ly/2ZrYPOP] Further company coverage: (Reuters.Briefs@thomsonreuters.com) Our Standards:The Thomson ...

TRVI Trevi Therapeutics, Inc. Common Stock

12d ago, source: Nasdaq

Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.

Trevi Therapeutics to Present at BMO Prescriptions for Success Healthcare Virtual Conference

20d ago, source: Morningstar%2c Inc.

About Trevi Therapeutics, Inc. Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious ...

Trevi Moran Releases New Song 'Cheers' From Upcoming EP 'Freedom'

6d ago, source: Just Jared Jr.

Trevi Moran just released the latest song from her upcoming EP Freedom! The 21-year-old singer and YouTuber debuted “Cheers” ...

Trevi Therapeutics Announces Election of Dominick C. Colangelo to Board of Directors

7d ago, source: Benzinga.com

NEW HAVEN, Conn., June 30, 2020 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. ("Trevi"), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER ...

BRIEF-Trevi Therapeutics Files For Mixed Shelf Of Up To $150 Million

11d ago, source: Reuters

June 26 (Reuters) - Trevi Therapeutics Inc: * TREVI THERAPEUTICS FILES FOR MIXED SHELF OF UP TO $150 MILLION - SEC FILING Source text: [bit.ly/2ZrYPOP] Further company coverage: (Reuters.Briefs@ ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.